Evidence map›Paper›PMID 36839520›Full record

ReviewPathogens (Basel, Switzerland)2023

Epidemiology of Ebolaviruses from an Etiological Perspective.

Sahil Jain, Svetlana Khaiboullina, Ekaterina Martynova, Sergey Morzunov, Manoj Baranwal

Abstract readReview
In one paragraph

Review in Pathogens (Basel, Switzerland), 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 9 papers.

0numbers the graph read from it
0cells of the map it votes in
9citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

9 citing papers in PubMed.

  1. Review
  2. Article
  3. Conserved Filovirus Proteins as Targets of Broad-Spectrum Antivirals.bioRxiv : the preprint server for biology · 2025
    Article
  4. The Ebola virus - going beyond the bleeding edge.Journal of medical microbiology · 2025
    Review
  5. Article
  6. Article
  7. Novel Antiviral Molecules against Ebola Virus Infection.International journal of molecular sciences · 2023
    Article
  8. Article
  9. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Sahil JainDepartment of Biotechnology, Thapar Institute of Engineering and Technology, Patiala 147004, Punjab, India.
Svetlana KhaiboullinaInstitute of Fundamental Medicine and Biology, Kazan Federal University, 420008 Kazan, Tatarstan, Russia.
Ekaterina MartynovaInstitute of Fundamental Medicine and Biology, Kazan Federal University, 420008 Kazan, Tatarstan, Russia.
Sergey MorzunovDepartment of Pathology, School of Medicine, University of Nevada, Reno, NV 89557, USA.
Manoj BaranwalDepartment of Biotechnology, Thapar Institute of Engineering and Technology, Patiala 147004, Punjab, India.ORCID 0000-0002-6581-9346

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Since the inception of the ebolavirus in 1976, 32 outbreaks have resulted in nearly 15,350 deaths in more than ten countries of the African continent. In the last decade, the largest (2013-2016) and second largest (2018-2020) ebolavirus outbreaks have occurred in West Africa (mainly Guinea, Liberia, and Sierra Leone) and the Democratic Republic of the Congo, respectively. The 2013-2016 outbreak indicated an alarming geographical spread of the virus and was the first to qualify as an epidemic. Hence, it is imperative to halt ebolavirus progression and develop effective countermeasures. Despite several research efforts, ebolaviruses' natural hosts and secondary reservoirs still elude the scientific world. The primary source responsible for infecting the index case is also unknown for most outbreaks. In this review, we summarize the history of ebolavirus outbreaks with a focus on etiology, natural hosts, zoonotic reservoirs, and transmission mechanisms. We also discuss the reasons why the African continent is the most affected region and identify steps to contain this virus.

Indexed as

ebolavirus in Africaebolavirus outbreaksebolavirus reservoirsebolavirus transmission

Identifiers

PMID36839520
PMCPMC9963726

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.